Panacea Biotec Limited

NSE:PANACEABIO.NS

415.9 (INR) • At close January 15, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 1,473.51,157.21,364.61,5051,430.21,291.91,289.31,1521,051.21,1071,387.231,558.82,321.71,324.51,611.091,417.61,820.21,327.61,184.861,677.41,251.81,257.81,223.461,103.81,203.3992.8
Kosten van de omzet 431.9879.5969.91,140.8581.9548.6574.8477.8364.51,109.51,069.07465.91,038.8426.3827.83425.1638394.4573.34522.8368.9280.71,093.59253.4435.4244.7
Brutowinst 1,041.6277.7394.7364.2848.3743.3714.5674.2686.7-2.5318.161,092.91,282.9898.2783.26992.51,182.2933.2611.521,154.6882.9977.1129.87850.4767.9748.1
Brutowinstmarge 0.7070.240.2890.2420.5930.5750.5540.5850.653-0.0020.2290.7010.5530.6780.4860.70.6490.7030.5160.6880.7050.7770.1060.770.6380.754
Onderzoek- en ontwikkelingskosten 000000328.2000358.03000390.17000107.08000255.83000
Algemene en administratieve kosten 000000247.49000471.63000456.96000396.65000393.75000
Verkoop- en marketingkosten 000000218.21000220.05000183.74000209.78000136.44000
Verkoop-, algemene en administratieve kosten 0504.9543.2456.8508.7359.7465.7440.4406.8320.8691.68456.7457.3469.6640.7391.7375.2351606.43367354.8321530.19315.3378.8395.9
Overige kosten 1,041.6740108.156.832.360.8150.6139.4104.5122.1-35.2316.620.332.3-30.6418.92011.9-108.4332.334.550.3-58.8532.917.129.7
Bedrijfskosten 1,041.6504.9543.2456.8977941.21,128.5595.1824896.1687.791,079.81,331.71,024.3832.86954.1915.9821.1401.52893.51,053.7856.9385.681,114.31,001.91,042.1
Bedrijfsresultaat 0-227.2-148.5-92.6-96.4-137.1-263.4384-32.8-776.5-391.5829.7-28.5-126.1-49.638.4266.3112.1133.99261.1-170.8120.2-255.81-263.9-234-294
Bedrijfsresultaat ratio 0-0.196-0.109-0.062-0.067-0.106-0.2040.333-0.031-0.701-0.2820.019-0.012-0.095-0.0310.0270.1460.0840.1130.156-0.1360.096-0.209-0.239-0.194-0.296
Totaal overige inkomsten en kosten netto 47.656.771.98-16.5-77.8-253.3445.55-129.6-135.3-188.316,479.54-504.7-481.3-446.6-476.96-438.5-454.4-439.8-802.4-439.4-533.9-3572,180.54174.2-751.1-663.9
Inkomen voor belasting 47.6-170.5-21.2-16.5-77.8130.3182.1224.4233.1-511.616,082.49-491.6-530.1-572.7-526.56-400.1-188.1-327.7-592.4-178.3-704.7-236.81,872.65-89.7-985.1-311.7
Inkomen voor belasting ratio 0.032-0.147-0.016-0.011-0.0540.1010.1410.1950.222-0.46211.593-0.315-0.228-0.432-0.327-0.282-0.103-0.247-0.5-0.106-0.563-0.1881.531-0.081-0.819-0.314
Belastingkosten 0.5-11.7-1.35.55.120.5308.930.776.149.83,707.850.400.814.870.40.93.491.523.123.528.325.9749-24.526.6
Nettowinst 48-158-14.3-22.8-82.9109.8-126.8193.7157-561.412,374.45-492-530.1-573.5-541.86-400.5-193.3-341.3-696.77-213.2-750-282.71,859.27-159.4-970-352.6
Nettowinstmarge 0.033-0.137-0.01-0.015-0.0580.085-0.0980.1680.149-0.5078.92-0.316-0.228-0.433-0.336-0.283-0.106-0.257-0.588-0.127-0.599-0.2251.52-0.144-0.806-0.355
WPA (Winst Per Aandeel) 0.77-2.59-0.23-0.37-1.351.78-2.073.162.56-9.17202.03-8.03-8.65-9.36-8.85-6.54-3.16-5.58-11.38-3.48-12.25-4.6230.39-2.6-15.83-5.75
Verwaterde WPA 0.77-2.59-0.23-0.37-1.351.78-2.073.162.56-9.17202.02-8.03-8.65-9.36-8.85-6.54-3.16-5.58-11.38-3.48-12.25-4.6230.39-2.6-15.83-5.75
EBITDA 144.2-74.575.183.124.4235.1287.7330.7343.8-398.616,500.7135.280.516.858.4170.4400.1237.3-48.9401.4-179.1284.8-663.8255.7-556.4-127.4
EBITDA ratio 0.098-0.064-0.044-0.001-0.002-0.0330.0730.190.063-0.61111.8870.0870.0350.0130.0340.120.220.1790.1980.239-0.020.226-0.5430.232-0.068-0.128